Margarida Maia, PhD, science writer —

Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.

Articles by Margarida Maia

MYELOMA

September 12, 2022 by Margarida Maia, PhD

Pepaxti Approved to Treat Resistant Multiple Myeloma in Europe

The European Commission has approved Pepaxti (melphalan flufenamide, also called melflufen), a medicine by Oncopeptides to be used in combination with dexamethasone, making it…

MYELOMA

July 18, 2022 by Margarida Maia, PhD

Pepaxti Combo Favored to Treat Advanced Multiple Myeloma in EU

Oncopeptides received a positive opinion from an arm of the European Medicines Agency (EMA) that is expected to take the company one step closer…

Margarida Maia, PhD, science writer —

Articles by Margarida Maia

Pepaxti Approved to Treat Resistant Multiple Myeloma in Europe

Pepaxti Combo Favored to Treat Advanced Multiple Myeloma in EU

Recent Posts